Drug Pricing Reforms To Underwrite Major Part Of Senate ‘Soft’ Infrastructure Legislation

Senate Finance Committee directed to provide ‘nearly all’ of the spending offsets for the $3.5tn package; Committee chair Ron Wyden is focused on authorizing the US government to directly negotiate drug prices in Medicare.

Senate Finance Committee Chairman Ron Wyden, D-OR. • Source: Alamy

US government price negotiation and price inflation rebates for prescription drugs in Medicare are two major revenue generators that Senate Democrats are counting on to fund a significant part of their $3.5tn so-called “soft” infrastructure legislation, according to a budget resolution plan released by Senate leaders 9 August.

The plan lays out a path for the Senate to pass the infrastructure provisions without Republican support as part of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet